Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CVRX NASDAQ:DXR NASDAQ:MGRM NASDAQ:OM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCVRXCVRx$9.95+4.6%$7.92$4.30▼$18.55$260.21M1.26203,247 shs308,385 shsDXRDaxor$12.95-0.4%$11.80$6.55▼$14.00$62.62M-0.066,105 shs1,826 shsMGRMMonogram Orthopaedics$6.00$5.77$1.92▼$6.43$243.79M0.68185,615 shsN/AOMOutset Medical$13.25-0.6%$13.91$5.85▼$25.35$235.40M2.13250,394 shs355,675 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVRXCVRx0.00%+11.17%+38.77%+24.38%+19.02%DXRDaxor0.00%+2.70%+13.60%+43.89%+41.68%MGRMMonogram Orthopaedics0.00%0.00%+3.99%+5.82%+151.05%OMOutset Medical0.00%+6.43%-6.49%-23.94%+40.21%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCVRXCVRx$9.95+4.6%$7.92$4.30▼$18.55$260.21M1.26203,247 shs308,385 shsDXRDaxor$12.95-0.4%$11.80$6.55▼$14.00$62.62M-0.066,105 shs1,826 shsMGRMMonogram Orthopaedics$6.00$5.77$1.92▼$6.43$243.79M0.68185,615 shsN/AOMOutset Medical$13.25-0.6%$13.91$5.85▼$25.35$235.40M2.13250,394 shs355,675 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVRXCVRx0.00%+11.17%+38.77%+24.38%+19.02%DXRDaxor0.00%+2.70%+13.60%+43.89%+41.68%MGRMMonogram Orthopaedics0.00%0.00%+3.99%+5.82%+151.05%OMOutset Medical0.00%+6.43%-6.49%-23.94%+40.21%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCVRXCVRx 2.63Moderate Buy$14.0040.70% UpsideDXRDaxor 2.50Moderate Buy$25.0093.05% UpsideMGRMMonogram Orthopaedics 2.67Moderate Buy$5.40-10.00% DownsideOMOutset Medical 2.50Moderate Buy$24.6786.16% UpsideCurrent Analyst Ratings BreakdownLatest DXR, CVRX, MGRM, and OM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025CVRXCVRxWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025DXRDaxorWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)10/8/2025MGRMMonogram OrthopaedicsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025OMOutset MedicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025CVRXCVRxWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025DXRDaxorWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)9/27/2025MGRMMonogram OrthopaedicsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025OMOutset MedicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)8/19/2025OMOutset MedicalRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSector Perform$22.008/7/2025OMOutset MedicalRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Perform$21.00 ➝ $22.008/5/2025CVRXCVRxCantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$11.00(Data available from 10/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCVRXCVRx$51.29M5.07N/AN/A$2.93 per share3.40DXRDaxorN/AN/AN/AN/AN/AN/AMGRMMonogram OrthopaedicsN/AN/AN/AN/A$0.42 per shareN/AOMOutset Medical$113.69M2.07N/AN/A$7.49 per share1.77Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCVRXCVRx-$59.97M-$2.10N/AN/AN/A-95.61%-79.31%-40.96%11/4/2025 (Estimated)DXRDaxorN/AN/A0.00∞N/AN/AN/AN/AN/AMGRMMonogram Orthopaedics-$16.33M-$0.50N/AN/AN/AN/A-126.82%-96.87%11/13/2025 (Estimated)OMOutset Medical-$127.98M-$20.29N/A∞N/A-82.06%-97.17%-32.84%11/5/2025 (Estimated)Latest DXR, CVRX, MGRM, and OM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/13/2025Q3 2025MGRMMonogram Orthopaedics-$0.10N/AN/AN/AN/AN/A11/5/2025Q3 2025OMOutset Medical-$0.64N/AN/AN/A$30.69 millionN/A11/4/2025Q3 2025CVRXCVRx-$0.50N/AN/AN/A$14.16 millionN/A8/15/2025Q2 2025MGRMMonogram Orthopaedics-$0.11-$0.16-$0.05-$0.16N/AN/A8/4/2025Q2 2025CVRXCVRx-$0.52-$0.57-$0.05-$0.57$13.22 million$13.59 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCVRXCVRxN/AN/AN/AN/AN/ADXRDaxorN/AN/AN/AN/AN/AMGRMMonogram OrthopaedicsN/AN/AN/AN/AN/AOMOutset MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCVRXCVRx0.8511.9910.78DXRDaxorN/AN/AN/AMGRMMonogram OrthopaedicsN/A2.162.16OMOutset Medical0.637.476.05Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCVRXCVRx75.27%DXRDaxor1.34%MGRMMonogram Orthopaedics0.45%OMOutset MedicalN/AInsider OwnershipCompanyInsider OwnershipCVRXCVRx13.90%DXRDaxor59.50%MGRMMonogram Orthopaedics28.10%OMOutset Medical2.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCVRXCVRx16026.15 million22.52 millionOptionableDXRDaxor374.84 million1.96 millionNot OptionableMGRMMonogram Orthopaedics2840.63 million29.21 millionNot OptionableOMOutset Medical52017.77 million17.34 millionNot OptionableDXR, CVRX, MGRM, and OM HeadlinesRecent News About These CompaniesOutset Medical (NASDAQ:OM) Trading Up 6.1% - Here's What HappenedOctober 15, 2025 | marketbeat.comReviewing Outset Medical (NASDAQ:OM) & PPJ Enterprise (OTCMKTS:PPJE)October 13, 2025 | americanbankingnews.comOutset Medical's (OM) Sell (D-) Rating Reaffirmed at Weiss RatingsOctober 10, 2025 | marketbeat.comOutset Medical: Revenue Trajectory Yet To Reflect Favorable Demand TailwindsSeptember 22, 2025 | seekingalpha.comOutset Medical, Inc. (OM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comOUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmSeptember 4, 2025 | globenewswire.comOutset Medical announces collaboration Northwest Kidney CentersSeptember 3, 2025 | msn.comNorthwest Kidney Centers Partners with Outset Medical to Enhance Home Hemodialysis Access with Tablo SystemSeptember 3, 2025 | quiverquant.comQNorthwest Kidney Centers and Outset Medical Announce Collaboration to Grow Home HemodialysisSeptember 3, 2025 | globenewswire.comOutset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare ConferenceAugust 20, 2025 | globenewswire.comOutset Medical’s Earnings Call Highlights Strong GrowthAugust 15, 2025 | theglobeandmail.comOutset Medical (OM) Receives a Hold from OppenheimerAugust 15, 2025 | theglobeandmail.comOutset Medical Inc.August 15, 2025 | barrons.comAfter Plunging 26.8% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical (OM)August 15, 2025 | zacks.comWhat To Expect From Outset Medical Inc (OM) Q2 2025 EarningsAugust 7, 2025 | finance.yahoo.comOutset Medical Reports Strong Q2 Growth and Raises GuidanceAugust 7, 2025 | msn.comOutset Medical, Inc. (OM) Q2 2025 Earnings Call TranscriptAugust 6, 2025 | seekingalpha.comOutset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue EstimatesAugust 6, 2025 | zacks.comOutset Medical Second-Quarter Results Demonstrate Continued Momentum, Punctuated by Strong Revenue Growth, Console Placements and UtilizationAugust 6, 2025 | globenewswire.comUncovering Potential: Outset Medical's Earnings PreviewAugust 5, 2025 | benzinga.comOutset Medical Appoints Brittni McGill as Chief Nursing Officer to Enhance Dialysis Care InnovationJuly 30, 2025 | quiverquant.comQNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDXR, CVRX, MGRM, and OM Company DescriptionsCVRx NASDAQ:CVRX$9.95 +0.44 (+4.63%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$10.16 +0.21 (+2.10%) As of 10/17/2025 05:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.Daxor NASDAQ:DXR$12.95 -0.05 (-0.38%) As of 10/17/2025 11:02 AM EasternDaxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.Monogram Orthopaedics NASDAQ:MGRM$6.00 0.00 (0.00%) As of 10/7/2025Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.Outset Medical NASDAQ:OM$13.25 -0.08 (-0.60%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$13.30 +0.04 (+0.34%) As of 10/17/2025 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom Inks OpenAI Deal: Why It's A Huge Win for AVGO Stock Institutions Are Fueling CrowdStrike’s Next Leg Higher This AI Chip Giant Could Be the Market’s Next Big Winner Microsoft & NVIDIA Unveil GB300 Supercomputer as AI Race Heats Up This Less-Hyped Tech Stock Could Be the Key to the Next AI Wave Archer Buys Rival's Patent Treasure Trove in Strategic Move Prologis Stock Surges: Why the Rally May Continue Intel's Turnaround Hits Hyperspeed With A New 52-Week High Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
